A Successor Fund Transfer (SFT) or merge is an opportunity for funds to create greater scale that can be readily translated to benefits for the member. In an environment of increasing investor advocacy, a merge that builds “cultural” scale could be an alternative for funds with a strong member voice.
Read MoreOne of the most important components of the due diligence process in superannuation fund mergers are cost projections and agreeing on who’s members are paying for what. There are many risks involved in mergers, but equally there are opportunity costs and risks associated with not doing it
Read MoreOne of the most important components of the due diligence process in superannuation fund mergers are cost projections and agreeing on who’s members are paying for what. There are many risks involved in mergers, but equally there are opportunity costs and risks associated with not doing it
Read MoreThe Australian Financial Complaints Authority will replace the Superannuation Complaints Tribunal; the Financial Ombudsman Service (FOS); and the Credit and Investments Ombudsman (CIO), no later than 1 November 2018.
Read MoreInvestment performance might ebb and flow like the tide, but fees are as certain as death and taxes. This truth – enabled by advances in data processing – has underpinned the rise of cheaper ways of investing over the past decade.
Read MoreThe superannuation industry should prepare for an “open super” regime in the next few years, in light of current moves towards “open data” and “open banking” and the fundamental shift in the balance of power in the information economy, says Jonathan Steffanoni, principal consultant – legal and risk at QMV.
Read MoreA continued regulatory focus on member outcomes will dominate the superannuation industry in 2018 and contribute to the continued consolidation of funds, says Mr Jonathan Steffanoni, Principal Consultant, Legal & Risk, QMV.
Read MoreData errors are costing the superannuation industry, and its customers, millions of dollars every year with poor data spreading like a disease through the system, says Mark Vaughan, managing director of QMV.
Read More
